Can 5-Amino-1MQ be combined with other compounds
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Factors such as initial B12 levels, underlying medical conditions, certain medications, advanced age, and injection frequency can affect the absorption and utilization of B12, possibly shortening the duration of action
It helps the liver detoxify by eliminating harmful substances from food, alcohol, and medications
Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme